Albert Labs International Corp. Share Price Deutsche Boerse AG
Equities
VB50
CA0127841041
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.006 EUR | 0.00% | 0.00% | +50.00% |
Sales 2021 | - | Sales 2022 | - | Capitalization | 2.73M 2.54M 228M |
---|---|---|---|---|---|
Net income 2021 | -1M -931K -83.53M | Net income 2022 | -7M -6.52M -585M | EV / Sales 2021 * | - |
Net cash position 2021 | 76.7K 71.4K 6.41M | Net cash position 2022 | 79.12K 73.65K 6.61M | EV / Sales 2022 | - |
P/E ratio 2021 * |
-
| P/E ratio 2022 |
-0.32
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 84.71% |
3 months | -14.29% | ||
6 months | +200.00% | ||
Current year | +50.00% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Raymont
CEO | Chief Executive Officer | 74 | - |
Robert Kang
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | 61 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Raymont
CEO | Chief Executive Officer | 74 | - |
Navchand Jagpal
COO | Chief Operating Officer | - | - |
Ravinder Kang
BRD | Director/Board Member | 58 | - |
Date | Price | Change |
---|---|---|
13/24/13 | 0.006 | 0.00% |
12/24/12 | 0.006 | 0.00% |
11/24/11 | 0.006 | 0.00% |
10/24/10 | 0.006 | 0.00% |
07/24/07 | 0.006 | 0.00% |
Delayed Quote Deutsche Boerse AG, June 13, 2024 at 11:42 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
+46.03% | 56.61B | |
-7.53% | 39.62B | |
+36.02% | 39.25B | |
-9.38% | 28.28B | |
+12.31% | 26.44B | |
-16.38% | 20.12B | |
+30.79% | 12.51B | |
+28.57% | 12.48B | |
-0.36% | 12.2B |
- Stock Market
- Equities
- ABRT Stock
- VB50 Stock